Johnson & Johnson is scheduled to release its Q2 earnings results on July 15, 2026, with analysts forecasting earnings of $2.85 per share and $25.05 billion in revenue. The company's stock rose 3.6% ahead of the announcement. Additionally, Zacks reports indicate that JNJ is among the companies poised to beat earnings estimates in their upcoming quarterly reports.
